Thursday, February 14, 2013

Deep genomic analysis identifies a micro RNA opponent for ovarian cancer

NCI Cancer Center News

Researchers led by MD Anderson Cancer Center employed an extensive analysis of genomic information to identify a new, high-risk cohort of ovarian cancer patients, characterize their tumors, find a potential treatment and test it in mouse models of the disease. The exhaustive analysis that led to micro RNA 506 (miR-506) as a potential therapeutic candidate for advanced or metastatic ovarian cancer is the cover article in the Feb. 11 edition of Cancer Cell.

Click here to read full press release.

###

NCI comprehensive cancer centers logoAmong the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer?s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers? research results are often at the forefront of studies in the cancer field.

Source: http://feedproxy.google.com/~r/ncinewsreleases/~3/P1w6rHHByGs/MicroRNAOpponentOvarianCancer

saul alinsky annapolis wwe royal rumble trisomy leon panetta luck sag awards 2012 nominees

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.